Last update 21 Nov 2024

CD19 CAR-T(Southwest Hospital, China)

Overview

Basic Info

Drug Type
CAR-T
Synonyms
Chimeric Antigen Receptor Modified T cells Targeting CD19
Target
CD19
Mechanism
CD19 modulators(B-lymphocyte antigen CD19 modulators)
Therapeutic Areas
NeoplasmsImmune System DiseasesHemic and Lymphatic Diseases
Active Indication-
Inactive Indication
CD19 Positive B-Cell LeukemiaCD19 positive B-Cell LymphomaDiffuse Large B-Cell Lymphoma
Originator Organization
Southwest Hospital, China
Active Organization-
Inactive Organization
Southwest Hospital, China
Drug Highest PhasePendingPhase 1/2
First Approval Date-
Regulation-
Login to view timeline

Related

3
Clinical Trials associated with CD19 CAR-T(Southwest Hospital, China)
NCT02846584 / Unknown statusPhase 2IIT
a Clinical Research of Sequential CAR-T Bridging Hematopoietic Stem Cell Transplantation in the Treatment of Relapse/Refractory B-cell Malignancies
NCT02737085 / Unknown statusPhase 1/2IIT
the Sequential Therapy of CD19-targeted and CD20-targeted CAR-T Cell Therapy for Diffuse Large B Cell Lymphoma(DLBCL)
NCT02349698 / Unknown statusPhase 1/2IIT
A Clinical Research of Chimeric Antigen Receptor (CAR) T Cells Targeting CD19 Positive Malignant B-cell Derived Leukemia and Lymphoma
100 Clinical Results associated with CD19 CAR-T(Southwest Hospital, China)
Login to view more data
100 Translational Medicine associated with CD19 CAR-T(Southwest Hospital, China)
Login to view more data
100 Patents (Medical) associated with CD19 CAR-T(Southwest Hospital, China)
Login to view more data
100 Deals associated with CD19 CAR-T(Southwest Hospital, China)
Login to view more data

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Diffuse Large B-Cell LymphomaPhase 2
CN
Southwest Hospital, China
01 Mar 2016
CD19 Positive B-Cell LeukemiaPhase 2
CN
Southwest Hospital, China
01 Dec 2014
CD19 positive B-Cell LymphomaPhase 2
CN
Southwest Hospital, China
01 Dec 2014
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date

No Data

Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free